Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Maiolino A, Crusoé EQ, Martinez GA, Braga WMT, de Farias DLC, Bittencourt RI, Neto JVP, Ribeiro GN, Bernardo WM, Tristão L, Magalhaes RJP, Hungria VTM. Maiolino A, et al. Among authors: magalhaes rjp. Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):410-418. doi: 10.1016/j.htct.2022.06.003. Epub 2022 Jul 20. Hematol Transfus Cell Ther. 2022. PMID: 35970751 Free PMC article. No abstract available.
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality -cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM).
Garnica M, Crusoe EQ, Ribeiro G, Bittencourt R, Magalhães RJP, Zanella KR, Hallack Neto AE, Lima JS, Solo CB, Souza EG, Fernandes AM, Maiolino A, Hungria V. Garnica M, et al. Among authors: magalhaes rjp. Hematol Transfus Cell Ther. 2024 Apr-Jun;46(2):153-160. doi: 10.1016/j.htct.2023.08.002. Epub 2023 Sep 13. Hematol Transfus Cell Ther. 2024. PMID: 37718131 Free PMC article.
Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil.
Salgado ABDS, Magalhães RJP, Pontes RM, Barbosa EDS, Flores-Montero J, Sanoja-Flores L, Land MGP, Pimenta G, Dutra HDS, Costa ES, Orfao A, Maiolino A. Salgado ABDS, et al. Among authors: magalhaes rjp. Cancers (Basel). 2023 Mar 4;15(5):1605. doi: 10.3390/cancers15051605. Cancers (Basel). 2023. PMID: 36900396 Free PMC article.
Bisphophonate alterations of the jaw bones in individuals with multiple myeloma.
Feitosa ÉF, Vasconcellos MM, Magalhães RJP, Domingos-Vieira AC, Visconti MA, Guedes FR, Maiolino A, Torres SR. Feitosa ÉF, et al. Among authors: magalhaes rjp. Dentomaxillofac Radiol. 2020 Feb;49(2):20190155. doi: 10.1259/dmfr.20190155. Epub 2019 Nov 12. Dentomaxillofac Radiol. 2020. PMID: 31670576 Free PMC article.
Oral health status of patients with multiple myeloma.
Feitosa ÉF, Magalhães RJP, Barbosa CAM, Guedes FR, Maiolino A, Torres SR. Feitosa ÉF, et al. Among authors: magalhaes rjp. Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):166-172. doi: 10.1016/j.htct.2019.01.012. Epub 2019 May 15. Hematol Transfus Cell Ther. 2020. PMID: 31582338 Free PMC article.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation.
Crusoe EQ, Higashi F, Martinez G, Bittencourt R, Pinto Neto JV, Sousa L, Santucci R, Magalhães RJP, Colli G, Nunes RFM, Ribeiro G, Nicacio J, Zanella KR, Kutner JM, Magalhaes A, Leao D, Hallack Neto AE, Braga W, Souza EG, Guimaraes AJAM, Durigon GS, Laks D, Maiolino A, Hungria VTM; GBRAM- (GRUPO BRASILEIRO DE MIELOMA). Crusoe EQ, et al. Among authors: magalhaes rjp. Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):118-124. doi: 10.1016/j.htct.2019.05.004. Epub 2019 Aug 12. Hematol Transfus Cell Ther. 2020. PMID: 31537476 Free PMC article.
New proteasome inhibitors in the treatment of multiple myeloma.
Hungria VTM, Crusoé EQ, Bittencourt RI, Maiolino A, Magalhães RJP, Sobrinho JDN, Pinto JV, Fortes RC, Moreira ES, Tanaka PY. Hungria VTM, et al. Among authors: magalhaes rjp. Hematol Transfus Cell Ther. 2019 Jan-Mar;41(1):76-83. doi: 10.1016/j.htct.2018.07.003. Epub 2018 Oct 15. Hematol Transfus Cell Ther. 2019. PMID: 30793108 Free PMC article. Review.
Can dentists detect multiple myeloma through oral manifestations?
Almeida TMX, Cavalcanti ÉFF, Freitas ADS, Magalhães RJP, Maiolino A, Torres SR. Almeida TMX, et al. Among authors: magalhaes rjp. Hematol Transfus Cell Ther. 2018 Jan-Mar;40(1):43-49. doi: 10.1016/j.bjhh.2017.08.006. Epub 2017 Nov 24. Hematol Transfus Cell Ther. 2018. PMID: 29519372 Free PMC article.
Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia.
García-Sanz R, Ocio E, Caballero A, Magalhães RJ, Alonso J, López-Anglada L, Villaescusa T, Puig N, Hernández JM, Fernández-Calvo J, Aguilar A, Martín A, López R, Paiva B, Orfao A, Vidriales B, San-Miguel JF, Del Carpio D. García-Sanz R, et al. Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):168-71. doi: 10.3816/CLML.2011.n.040. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21856552